| __timestamp | Grifols, S.A. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 382096000000 |
| Thursday, January 1, 2015 | 224193000 | 345927000000 |
| Friday, January 1, 2016 | 197617000 | 312303000000 |
| Sunday, January 1, 2017 | 288320000 | 325441000000 |
| Monday, January 1, 2018 | 240661000 | 368298000000 |
| Tuesday, January 1, 2019 | 276018000 | 492381000000 |
| Wednesday, January 1, 2020 | 294216000 | 455833000000 |
| Friday, January 1, 2021 | 354881000 | 526087000000 |
| Saturday, January 1, 2022 | 361140000 | 633325000000 |
| Sunday, January 1, 2023 | 330551000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Takeda Pharmaceutical Company Limited and Grifols, S.A. are two industry titans, each with a unique approach to research and development (R&D) investment. Over the past decade, Takeda has consistently outpaced Grifols, investing nearly 1,700% more in R&D annually. From 2014 to 2023, Takeda's R&D expenses surged from approximately $382 billion to $730 billion, reflecting a robust commitment to innovation. In contrast, Grifols' investment grew from $181 million to $331 million, a commendable increase but dwarfed by Takeda's scale. This disparity highlights Takeda's strategic focus on pioneering new treatments and therapies. As we look to the future, the question remains: will Grifols ramp up its investment to compete with Takeda's innovation-driven growth?
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Veracyte, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.